Extended-spectrum β-lactamases (ESBLs) are the enzymes that hydrolyze a wide variety of β-lactam antibiotics including oxyimino-cephalosporins and monobactams. Infections caused by ESBL-producing strains are increasing in the community and in hospitals. These organisms are typically multi-drug resistant and the risk of inadequate empiric therapy. In Iraq, infections caused by ESBL-producing bacteria have increased dramatically and have become a serious problem nationwide. Therefore, there is an increased demand to determine the distribution of these organisms in community and...